VTGN icon

VistaGen Therapeutics
VTGN

Overview Fund Activity

101 hedge funds and large institutions have $387M invested in VistaGen Therapeutics in 2021 Q2 according to their latest regulatory filings, with 46 funds opening new positions, 23 increasing their positions, 22 reducing their positions, and 19 closing their positions.

Holders
101
Holders Change
+27
Holders Change %
+36.49%
% of All Funds
1.76%
Holding in Top 10
2
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.03%
New
46
Increased
23
Reduced
22
Closed
19
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

1
BlackRock
1
BlackRock
New York
$36.7M
2
O
2
OrbiMed
New York
$45.6M
3
Vanguard Group
3
Vanguard Group
Pennsylvania
$28M
4
State Street
4
State Street
Massachusetts
$9.64M
5
Geode Capital Management
5
Geode Capital Management
Massachusetts
$9.49M

Top Sellers

1
GTC
1
Ghost Tree Capital
New York
$6.3M
2
IC
2
Ikarian Capital
Texas
$2.89M
3
MWNA
3
Marshall Wace North America
New York
$0
4
Millennium Management
4
Millennium Management
New York
$557K
5
SB
5
Samsara BioCapital
California
$2.31M
Name Market Value Shares Shares
Change 		Shares
Change %
NMC
1
NEA Management Company
Maryland
$51.4M 16,302,596 – –
VA
2
VR Adviser
New York
$50.5M 16,047,286 -255,310 -2%
O
3
OrbiMed
New York
$45.6M 14,467,872 +5,863,872 +68%
ACP
4
Acuta Capital Partners
California
$36.9M 11,728,033 -567,734 -5%
BlackRock
5
BlackRock
New York
$36.7M 11,650,018 +8,996,421 +339%
Franklin Resources
6
Franklin Resources
California
$31.3M 9,940,637 -925,300 -9%
Vanguard Group
7
Vanguard Group
Pennsylvania
$28M 8,882,942 +3,078,523 +53%
SFM
8
Sphera Funds Management
Israel
$12.9M 4,080,673 -96,485 -2%
CC
9
Commodore Capital
New York
$10.5M 3,331,315 -398,379 -11%
State Street
10
State Street
Massachusetts
$9.64M 3,059,610 +3,059,610 New
Geode Capital Management
11
Geode Capital Management
Massachusetts
$9.49M 3,013,208 +1,976,385 +191%
NIP
12
Nicholas Investment Partners
California
$8.68M 2,753,880 +592,878 +27%
Northern Trust
13
Northern Trust
Illinois
$6.55M 2,079,179 +1,816,239 +691%
GTC
14
Ghost Tree Capital
New York
$6.3M 2,000,000 -2,143,702 -52%
Two Sigma Investments
15
Two Sigma Investments
New York
$3.75M 1,189,121 +251,165 +27%
EP
16
EPIQ Partners
Minnesota
$2.94M 932,956 +51,000 +6%
IC
17
Ikarian Capital
Texas
$2.89M 916,552 -1,969,400 -68%
SB
18
Samsara BioCapital
California
$2.31M 732,596 -1,098,894 -60%
Nuveen Asset Management
19
Nuveen Asset Management
Illinois
$2.16M 686,380 +686,380 New
Two Sigma Advisers
20
Two Sigma Advisers
New York
$1.99M 631,000 -74,700 -11%
SSA
21
Schonfeld Strategic Advisors
New York
$1.93M 613,600 +343,801 +127%
Goldman Sachs
22
Goldman Sachs
New York
$1.84M 584,902 +356,594 +156%
Charles Schwab
23
Charles Schwab
California
$1.5M 474,361 +424,584 +853%
Bank of New York Mellon
24
Bank of New York Mellon
New York
$1.48M 468,935 +406,107 +646%
Victory Capital Management
25
Victory Capital Management
Texas
$1.42M 449,800 +112,020 +33%
1
2 3 4 5